[보안 로그인 하기]
[회원가입]  [ID/PW찾기]
대한민국 원환율 (2021-08-27)
통화 금액
USD 1,170
EUR 1,377
GBP 1,603
JPY 1,065
CAD 925
Cardiovascular Prevention and Rehabilitation in Practice-2판
Cardiovascular Prevention
       판매가 : 80,00072,000
       적립금 : 1,440
       저   자 : Jones
       역   자 :
       출판사 : Wiley
    ISBN(13) : 9781118458693
       발행일 : 2020-03-30  /   2판   /   336 페이지
       상품코드 : 27603
       수 량 :
       

Description:


The authoritative clinical handbook promoting excellence and best practice
Cardiovascular Prevention and Rehabilitation in Practice is a comprehensive, practitioner-focused clinical handbook
which provides internationally applicable evidence-based standards of good practice. Edited and written by a
multidisciplinary team of experts from the British Association for Cardiovascular Prevention and Rehabilitation
(BACPR), this book is invaluable for practitioners helping people with heart disease return to health. The text
provides an overview of research findings, examines the core components of cardiac rehabilitation, and discusses
how to support healthier lifestyles and reduce the risks of recurrence.

Now in its second edition, this textbook has been fully revised to incorporate recent clinical evidence and align
with current national and international guidelines. Increased emphasis is placed on an integrated approach to cardiac
rehabilitation programmes, whilst six specified standards and six core components are presented to promote sustainable
health outcomes.

  • Describes how cardiovascular prevention and rehabilitation programmes can be delivered to meet standards of good
    practice
  • Covers a broad range of topics including: promoting health behaviour change to improve lifestyle risk factors,
    supporting psycho-social health, managing medical risk factors, and how to develop long-term health strategies
  • Emphasises the importance of early programme commencement with assessment and reassessment of patient goals and
    outcomes, and gives examples of strategies to achieve these
  • Discusses the role of programme audit and certification of meeting minimum standards of practice
  • Looks to the future and how delivery of cardiovascular prevention and rehabilitation programmes internationally
    will need to meet common challenges



  • CHAPTER 1: Cardiovascular Disease Prevention and Rehabilitation
    1.1 RATIONALE AND AIMS
    1.2 THE BURDEN OF CVD
    1.3 DEFINING CR AND CARDIOVASCULAR PREVENTION AND REHABILITATION
    더보기

    1.4 THE COMPELLING CASE FOR CARDIOVASCULAR PREVENTION AND REHABILITATION
    1.5 SERVICE PROVISION AND UPTAKE
    1.6 EMPLOYING EVIDENCE‐BASED APPROACHES TO INCREASE PARTICIPATION
    1.7 FUTURE PERSPECTIVES
    1.8 CONCLUSION

    CHAPTER 2: Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation

    2.1 RATIONALE AND AIMS
    2.2 SIX STANDARDS TO ACHIEVE HIGH QUALITY CARDIOVASCULAR PREVENTION AND REHABILITATION
    2.3 THE CORE COMPONENTS

    CHAPTER 3: Delivering Quality Standards
    3.1 RATIONALE AND AIMS
    3.2 MAINTAINING EVIDENCE‐BASED PRACTICE
    3.3 STANDARD 1: THE DELIVERY OF SIX CORE COMPONENTS BY A QUALIFIED AND COMPETENT MULTIDISCIPLINARY TEAM, LED BY A
    CLINICAL COORDINATOR
    더보기

    3.4 STANDARD 2: PROMPT IDENTIFICATION, REFERRAL, AND RECRUITMENT OF ELIGIBLE PATIENT POPULATIONS
    3.5 STANDARD 3: EARLY INITIAL ASSESSMENT OF INDIVIDUAL PATIENT NEEDS WHICH INFORMS THE AGREED PERSONALISED GOALS THAT
    ARE REVIEWED REGULARLY
    3.6 STANDARD 4: EARLY PROVISION OF A STRUCTURED CPRP, WITH A DEFINED PATHWAY OF CARE, WHICH MEETS THE INDIVIDUAL'S
    GOALS AND IS ALIGNED WITH PATIENT PREFERENCE AND CHOICE
    3.7 CONCLUSION

    CHAPTER 4: Health Behaviour Change and Education
    4.1 RATIONALE AND AIMS
    4.2 HEALTH BEHAVIOUR CHANGE – THEORETICAL FOUNDATIONS
    4.3 HEALTH BEHAVIOUR CHANGE – ADDITIONAL CONCEPTS
    더보기

    4.4 HEALTH BEHAVIOUR CHANGE – TRANSLATING THEORY INTO PRACTICE
    4.5 BRINGING IT ALL TOGETHER – GOAL‐SETTING AS A PRACTICAL EXAMPLE
    4.6 IMPROVING ADHERENCE TO TREATMENT RECOMMENDATIONS
    4.7 THE ROLE OF SOCIAL SUPPORT IN HEALTH BEHAVIOUR CHANGE
    4.8 EDUCATION IN CARDIOVASCULAR PREVENTION AND REHABILITATION
    4.9 FLEXIBILITY OF APPROACHES TO CARDIOVASCULAR PREVENTION AND REHABILITATION – WHY DO WE NEED A MENU OF OPTIONS?
    4.10 MAXIMISING GROUP DYNAMICS – TIPS FOR SUCCESSFUL GROUP SUPPORT
    4.11 CLOSED VERSUS OPEN GROUPS
    4.12 HOW WILL THE COMPONENT BE ASSESSED AND MONITORED?
    4.13 CONCLUSION

    CHAPTER 5: Lifestyle Risk Factor Management
    INTRODUCTION

    CHAPTER 5A: Achieving Long‐term Abstinence from Tobacco Use in Patients in a Cardiovascular Prevention
    and Rehabilitation Setting

    5A.1 RATIONALE AND AIMS
    5A.2 DEPENDENCE ON TOBACCO
    5A.3 ASSESSMENT
    더보기

    5A.4 PROVIDING SUPPORT
    5A.5 VARENICLINE
    5A.6 NICOTINE REPLACEMENT THERAPY
    5A.7 COMBINING VARENICLINE WITH COMBINATION NRT
    5A.8 BUPROPION
    5A.9 EFFICACY AND SAFETY
    5A.10 ELECTRONIC CIGARETTES
    5A.11 CONCLUSION
    5A.12 COMPONENT LEADERS WITHIN A CPRP
    5A.13 WEIGHT GAIN AND SMOKING CESSATION
    5A.14 HARM REDUCTION

    CHAPTER 5B: Diet and Weight Management
    5B.1 RATIONALE AND AIMS
    5B.2 INFLUENCES OF DIETARY INTAKE
    5B.3 ASSESSMENT METHODS OF DIETARY INTAKE
    더보기

    5B.4 ASSESSMENT OF BODY COMPOSITION
    5B.5 COMPONENTS OF CARDIOPROTECTIVE DIETARY ADVICE
    5B.6 WEIGHT LOSS, MAINTENANCE, AND AVOIDANCE OF CYCLING, INCLUDING PHARMACOLOGICAL SUPPORT
    5B.7 COMMON MISCONCEPTIONS AND FREQUENTLY ASKED QUESTIONS
    5B.8 RELATIONSHIP WITH OTHER LONG‐TERM CONDITIONS
    5B.9 CONCLUSION

    CHAPTER 5C: Physical Activity and Exercise
    5C.1 RATIONALE AND AIMS
    5C.2 CONSISTENCY IN COMMUNICATING CONCEPTS TO PATIENTS
    5C.3 PHYSICAL ACTIVITY WITHIN THE CONTEXT OF CARDIOVASCULAR HEALTH
    더보기

    5C.4 MOVING FROM TRADITIONAL TO CONTEMPORARY MODELS OF PHYSICAL ACTIVITY AND REHABILITATION
    5C.5 KEY ISSUES FOR EARLY COMMENCEMENT OF EXERCISE
    5C.6 EMERGING AREAS RELATED TO ACTIVITY INTENSITY – FROM SEDENTARY BEHAVIOUR, LIGHT MOBILITY, AND MODERATE INTENSITY
    TO
    HIGH INTENSITY INTERVAL TRAINING
    5C.7 ASSESSING FUNCTIONAL CAPACITY AND PHYSICAL ACTIVITY – GUIDANCE, PRESCRIPTION, AND RISK STRATIFICATION OUTCOMES
    EVALUATION AND AUDIT
    5C.8 STAFFING, CORE, AND QUALITY STANDARDS
    5C.9 FUTURE CHALLENGES FOR EXERCISE IN CARDIOVASCULAR DISEASE PREVENTION AND REHABILITATION
    5C.10 OVERARCHING GUIDANCE
    5C.11 SPECIFIC PHYSICAL ACTIVITY AND EXERCISE GOALS AND GUIDANCE
    5C.12 SPECIFIC EXERCISE SESSIONS
    5C.13 PROGRAMME OUTCOMES
    5C.14 CONCLUSION

    CHAPTER 6: Psychosocial Health
    6.1 RATIONALE AND AIMS
    6.2 PSYCHOLOGICAL FACTORS RELATED TO HEART DISEASE
    6.3 DEVELOPING PSYCHOLOGICAL AWARENESS IN TEAMS
    더보기

    6.4 ASSESSMENT ISSUES
    6.5 INTERVENTIONS
    6.6 SEXUAL ASSESSMENT AND COUNSELLING
    6.7 RUNNING GROUPS
    6.8 THE INFLUENCE OF SOCIAL SUPPORT AND HOW WE CAN IMPROVE THIS
    6.9 PREPARING FOR THE END OF THE GROUP
    6.10 VOCATIONAL INTERVENTIONS
    6.11 WHEN TO REFER ON
    6.12 CONCLUSION

    CHAPTER 7: Medical Risk Management
    7.1 RATIONALE AND AIMS
    7.2 BLOOD PRESSURE
    7.3 LIPIDS
    더보기

    7.4 LIPID‐LOWERING THERAPY
    7.5 DYSGLYCAEMIA
    7.6 MEDICAL RISK FACTORS AND OTHER LONG‐TERM CONDITIONS
    7.7 CARDIOPROTECTIVE DRUG AND DEVICE THERAPIES
    7.8 ACE INHIBITORS/ANGIOTENSIN II RECEPTOR BLOCKERS
    7.9 MINERALOCORTICOID RECEPTOR ANTAGONIST
    7.10 LOOP DIURETICS
    7.11 STATIN THERAPY
    7.12 ANTI‐COAGULANT THERAPIES
    7.13 IMPLANTABLE DEVICES
    7.14 SPECIFIC ISSUES FOR PATIENTS WITH DEVICES
    7.15 CARDIOPROTECTIVE THERAPIES AND OTHER LONG‐TERM CONDITIONS
    7.16 MEDICAL MANAGEMENT IN ERECTILE DYSFUNCTION
    7.17 CONCLUSION

    CHAPTER 8: Long‐term Management
    8.1 RATIONALE AND AIMS
    8.2 PRIMARY CARE SERVICES
    8.3 LONG‐TERM MANAGEMENT OF RISK FACTORS
    더보기

    8.4 SELF‐MANAGEMENT
    8.5 SELF‐MONITORING AND TECHNOLOGY
    8.6 HEART SUPPORT GROUPS
    8.7 CONCLUSION

    CHAPTER 9: Audit and Evaluation
    9.1 CLINICAL AUDIT IN THE CONTEXT OF RESEARCH AND SERVICE EVALUATION
    9.2 ROLE OF NATIONAL AUDITS
    9.3 ESTABLISH WHICH FACTORS BEST DETERMINE OPTIMAL ACCESS AND CLINICAL OUTCOME
    더보기

    9.4 PROFILE AND OUTCOMES OF CR IN THE UK
    9.5 MONITORING STANDARDS THROUGH NATIONAL AUDIT
    9.6 NCP_CR THROUGH THE BACPR AND NACR
    9.7 ONGOING AND FUTURE RESEARCH
    9.8 CONCLUSION

    CHAPTER 10: Future Prospects and International Perspectives
    10.1 FUTURE PROSPECTS (JOE MILLS)
    10.2 COMMONWEALTH AND INTERNATIONAL PERSPECTIVES ON APPLICATIONS OF BACPR STANDARDS AND CORE COMPONENTS
    10.3 AUSTRALIAN CARDIOVASCULAR HEALTH AND REHABILITATION ASSOCIATION PERSPECTIVES O



    클릭 하시면 에스크로 가입여부를 확인 하실 수 있습니다.